• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

Elvitegravir

Rationale and Goals Determine inter- and intraobserver variability of computed tomography

May 31, 2017 by Katherine Lewis Leave a Comment

Rationale and Goals Determine inter- and intraobserver variability of computed tomography (CT) tumor quantity measurements in advanced non-small-cell lung cancers (NSCLC) sufferers treated within Elvitegravir a Stage II clinical trial using upper body CT. separately measured the tumor size CT and volume attenuation coefficient using commercially available volume analysis software. Concordance relationship coefficients (CCCs) and … [Read more…]

Posted in: DNA Topoisomerase Tagged: Elvitegravir, Epha1

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by